206 related articles for article (PubMed ID: 3534689)
21. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
[No Abstract] [Full Text] [Related]
22. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
Graham-Pole J; Lazarus HM; Herzig RH; Gross S; Coccia P; Weiner R; Strandjord S
Am J Pediatr Hematol Oncol; 1984; 6(1):17-26. PubMed ID: 6370012
[TBL] [Abstract][Full Text] [Related]
23. Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
Bitran JD; Samuels B; Klein L; Hanauer S; Johnson L; Martinec J; Harris E; Kempler J; White W
Bone Marrow Transplant; 1996 Feb; 17(2):157-62. PubMed ID: 8640160
[TBL] [Abstract][Full Text] [Related]
24. [Massive chemotherapy and purged bone marrow autograft in severe neuroblastoma. Preliminary results apropos of 5 cases].
Frappaz D; Philip T; Philip I; Biron P; Bouffet E; Favrot M; Veley B; Martinez MF; Lacroze M; Dutou L
Pediatrie; 1985; 40(7):539-51. PubMed ID: 3913896
[TBL] [Abstract][Full Text] [Related]
25. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
26. Syngeneic bone marrow transplantation in a patient with metastatic neuroblastoma refractory to conventional therapy.
Spruce WE; Blume KG; Ellington OB; Schmidt GM; Zusman J
Pediatrics; 1980 Mar; 65(3):573-4. PubMed ID: 6987605
[TBL] [Abstract][Full Text] [Related]
27. High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study.
Pardo N; Martí F; Fraga G; Illa J; Badell I; Peiró M; Bertran E; García J; Rueda F; Cubells J
Med Pediatr Oncol; 1996 Dec; 27(6):534-9. PubMed ID: 8888813
[TBL] [Abstract][Full Text] [Related]
28. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
[No Abstract] [Full Text] [Related]
29. Central nervous system relapse following bone marrow transplantation in stage IV neuroblastoma.
Palasis S; Morris J; Egelhoff JC
Pediatr Hematol Oncol; 1999; 16(5):443-52. PubMed ID: 10505321
[TBL] [Abstract][Full Text] [Related]
30. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
[TBL] [Abstract][Full Text] [Related]
31. [Intensive chemotherapy followed by autologous bone marrow transplantation in solid tumors in childhood].
de Kraker J; Voûte PA; Behrendt H
Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2302-5. PubMed ID: 6392905
[No Abstract] [Full Text] [Related]
32. High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.
McElwain TJ; Hedley DW; Gordon MY; Jarman M; Millar JL; Pritchard J
Exp Hematol; 1979; 7 Suppl 5():360-71. PubMed ID: 400698
[TBL] [Abstract][Full Text] [Related]
33. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
34. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of neuroblastoma: role of total body irradiation].
Franzone P; Corvò R; Dini G; Perin GP; Scarpati D
Radiol Med; 1986 Dec; 72(12):959-62. PubMed ID: 3541069
[TBL] [Abstract][Full Text] [Related]
36. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
37. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
38. Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma.
Valteau-Couanet D; Benhamou E; Vassal G; Stambouli F; Lapierre V; Couanet D; Lumbroso J; Hartmann O
Bone Marrow Transplant; 2000 May; 25(9):937-42. PubMed ID: 10800060
[TBL] [Abstract][Full Text] [Related]
39. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ
Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation.
Cornbleet MA; Corringham RE; Prentice HG; Boesen EM; McElwain TJ
Cancer Treat Rep; 1981; 65(3-4):241-4. PubMed ID: 7016319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]